Advertisement
AAEM Clinical Practice| Volume 58, ISSUE 4, P706-709, April 2020

Download started.

Ok

Should Antiemetics be Given Prophylactically with Intravenous Opioids While Treating Acute Pain in the Emergency Department?

Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee

      Abstract

      Background

      It is common practice for emergency physicians to give parenteral opioids for acute pain, however, some treating physicians have concerns that using parenteral opioids can lead to nausea and vomiting when used alone. Therefore, antiemetics are often given prophylactically with opioids for nausea and vomiting in the emergency department (ED). This systematic review evaluates the use of prophylactic antiemetics with parenteral opioids for the treatment of acute pain in the ED.

      Methods

      A 10-year literature search using keywords was performed in PubMed for English-language human studies. Abstracts were screened to identify high-quality studies, which then underwent a more rigorous structured review. The recommendations are made based on the literature review.

      Results

      Eight articles met criteria for structured review and citation in this article. These include one review article, two randomized controlled trials, three prospective observational trials, one retrospective study, and one pre- and post-intervention trial.

      Conclusions

      Based on the literature review, routine use of prophylactic antiemetics are not indicated with administration of parenteral opioids for treatment of acute pain in the ED, as nausea and vomiting are infrequent side effects. The recent literature clearly demonstrates that there are potential undesirable side effects from the use of antiemetics when using opioids. However, one subgroup of patients, those with a known history of nausea and vomiting after opioid use or a history of travel sickness, may benefit from the use of prophylactic antiemetic when being treated with parenteral opioids.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Porrecca F.
        • Ossipov M.H.
        Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanism, implications, and management options.
        Pain Med. 2009; 10: 654-662
        • Benyamin R.
        • Trescot A.M.
        • Datta S.
        • et al.
        Opioid complications and side effects.
        Pain Physician. 2008; 11: S105-S120
        • Nicholson B.
        Economic and clinical burden of opioid-induced nausea and vomiting.
        Postgrad Med. 2016; 129: 111-117
        • National Institute of Health
        MedlinePlus. Metoclopramide.
        (Available at:)
        • National Institute of Health
        MedlinePlus. Ondansetron.
        (Available at:)
        • Talbot-Stern J.
        • Paoloni R.
        Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED.
        Am J Emerg Med. 2000; 18: 653-657
        • Paoloni R.
        • Talbot-Stern J.
        Low incidence of nausea and vomiting with intravenous opiate analgesia in the ED.
        Am J Emerg Med. 2002; 20: 604-608
        • Bradshaw M.
        • Sen A.
        Use of a prophylactic antiemetic with morphine in acute pain: randomised controlled trial.
        Emerg Med J. 2006; 23: 210-213
        • Yeoh B.S.
        • Taylor D.M.
        • Taylor S.E.
        Education initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department.
        Emerg Med Australas. 2009; 21: 178-183
        • Culver M.A.
        • Richards E.C.
        • Jarrell D.H.
        • Edwards C.J.
        Use of prophylactic ondansetron with intravenous opioids in emergency department patients: a prospective observational pilot study.
        J Emerg Med. 2017; 53: 629-634
        • Bounes V.
        • Charriton-Dadone B.
        • Levraut J.
        • et al.
        Predicting morphine related side effect in the ED: an international cohort study.
        Am J Emerg Med. 2017; 35: 531-535
        • Ishihara M.
        • Ikesue H.
        • Matsunaga H.
        • et al.
        A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
        Clin J Pain. 2012; 28: 373-381